1. Medicine and Healthcare products Regulatory Agency. NIBSC. TGN1412 – learning from a clinical trials disaster. https://www.nibsc.org/about_us/worldwide_impact/tgn1412.aspx.
2. Gibb F. Victim Ryan Wilson in “elephant man” drug trial to get £2m. The Times, London. 2008.
3. Expert Group on Phase One Clinical Trials. Final report. 2006. https://webarchive.nationalarchives.gov.uk/ukgwa/+/dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/dh_063117.
4. Medicines and Healthcare Products Regulatory Agency (MHRA). Clinical trial suspension: latest findings, 5 Apr 2006. https://www.ema.europa.eu/en/news/first-man-clinical-trials-guideline-released-public-consultation. http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON2023515.
5. WHO International Drug Monitoring Centre (Uppsala, Sweden), Edwards IR, et al. Harmonisation in pharmacovigilance. Drug Saf. 1994;10(2):93–102.